Last reviewed · How we verify
proparacaine HCL 0.5%
At a glance
| Generic name | proparacaine HCL 0.5% |
|---|---|
| Sponsor | Illinois Retina Associates |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections (PHASE4)
- Efficacy of Nanodropper-mediated Topical Anesthetic (PHASE4)
- Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)
- Study of Stimulus Parameters in Flicker Electroretinogram (ERG) (NA)
- Base Curves of Bandage Contact Lenses and Their Effects on Post Trans-PRK Vision and Pain (NA)
- A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population (PHASE3)
- Wearing-Off Period of Pharmacological Dilation and Anisocoria (PHASE4)
- Does Topical Ophthalmic Anesthetic Prior to Probing and Irrigation Decrease Pain? (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |